prism 6 for mac os x version 6.0c (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
prism 6 for mac os x version 6.0c
Prism 6 For Mac Os X Version 6.0c, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+6+for+mac+os+x+version+6%2E0c/prism+software/us11389495-336-40-48
Average 90 stars, based on 1 article reviews
Prism 6 For Mac Os X Version 6.0c, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/prism+6+for+mac+os+x+version+6%2E0c/prism+software/us11389495-336-40-48
Average 90 stars, based on 1 article reviews
prism 6 for mac os x version 6.0c - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: CCTA in patients with positive troponin and low clinical suspicion for ACS: a useful diagnostic option to exclude obstructive CAD. Article Snippet: Purpose It is uncertain whether patients with elevated troponin and non-classical presentation of acute coronary syndrome (ACS) should receive coronary CTangiography (CCTA).. A proportion of these patients will have no coronary artery disease (CAD) and would benefit from non-invasive investigations and expedited discharge.. Objectives were to determine most common diagnoses and rate of ACS among patients with positive troponin and low clinical suspicion of ACS who received CCTA. Article Title: Combination method for treatment of cancer Article Snippet: No statistically significant differences in the mean body weight were observed between the treatment groups and NTC mice at any time points (results not shown; multiple t-tests corrected for multiple comparisons using the Holm-Sidak method) [Prism 6 for Article Title: Combination method for treatment of cancer Article Snippet: No statistically significant differences in the mean body weight were observed between the treatment groups and NTC mice at any time points (multiple t-tests corrected for multiple comparisons using the Holm-Sidak method) except for the UV-CVA21+anti-PD-1 group at day 31 (Prism 6 for Article Title: Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures Article Snippet: Analyses were carried out using Prism 6 for |